Sharp Statement on the Impact of COVID-19
COVID-19 response: Updated December 2021 As we are all aware, this COVID-19 pandemic will persist for some time. Sharp continues to prioritize the health…
COVID-19 response: Updated December 2021 As we are all aware, this COVID-19 pandemic will persist for some time. Sharp continues to prioritize the health…
Sharp Clinical Services, a part of UDG Healthcare and a leading provider of global clinical supply services, has added three key members to its business development team.
December 10th, 2019 Sharp, a leading provider of pharmaceutical packaging and clinical services, has strengthened its leadership team with two new additions to its…
October 10th, 2019 Sharp, a global leader in contract packaging and clinical supply services, officially opened its new £9.5 million facility in Rhymney at…
September 26th, 2019 Sharp, a leading provider of clinical supply services, has strengthened its leadership team with the appointment of Sascha Sonnenberg as Global…
September 19th, 2019 Sharp, a global leader in contract packaging and clinical supply services, is to officially open its new £9.5 million facility in…
Sharp – part of UDG Healthcare plc, a global leader in contract packaging and clinical supply services, has received Wholesale Distribution Authorisation (WDA) and Investigational Medicinal Product (IMP) licensing approvals to support clinical activities from its facility in Heerenveen, Netherlands.
April 24th, 2019 Sharp, a global leader in contract packaging and clinical supply services, has invested $21 million in expanding capacity and capabilities at…
Sharp has received approval from the Medicines and Healthcare Product Regulatory Agency (MHRA) to begin production at its Clinical Services Centre of Excellence in Rhymney, UK.
Sharp, part of UDG Healthcare, a leading provider of pharmaceutical packaging and clinical services, has strengthened its leadership team with the appointment of Kevin Orfan as president of Sharp Packaging US.
Sharp has announced a $650,000 investment into enhancing its Interactive Response Technology (IRT) solution. Sharp’s IRT solution is used to manage patient interactions and drug supplies during clinical trials and perform a range of functions for sponsors, drug depots and investigative sites.
Sharp has completed its relocation to its $23m state-of-the-art facility in Bethlehem, PA.
Rachel Curran, Head of Commercial Services, reflects on her 25 years with Sharp and shares the incredible journey from a small family-owned business in Llangattock, South Wales, to being part of a world-class pharmaceutical manufacturing, packaging, storage and distribution facility in Rhymney, Wales.
Sharp has confirmed a preferred partner agreement with innovative sterile manufacturer Berkshire Sterile Manufacturing (BSM).
October 5th, 2018 Sharp, a global leader in contract packaging and clinical supply services, has formed a long-term, strategic partnership with Santen Pharmaceuticals to…